Canine Multifocal Retinopathy (CMR)

What It Is

Canine multifocal retinopathy is a group of inherited retinal disorders characterized by multifocal retinal lesions, often associated with BEST1-related retinal pigment epithelium dysfunction in specific genetic forms.

Also Called: canine multifocal retinopathy; multifocal retinopathy

Abbreviation: CMR

Breeds Affected: Brazilian Terrier; Coton de Tuléar; Lapponian Herder


The Idiot-Proof Explanation

CMR is an inherited retina problem where spots or blister-like lesions can develop in the back of the eye. Some dogs keep decent vision. Some have retinal changes that matter more. Either way, this is not something an owner can see by staring lovingly into the dog’s face at breakfast.


What Causes It

CMR is inherited. The known numbered forms are tied to specific genetic testing language, and those subtypes should be handled separately so breed risk and testing information do not get mashed together like spreadsheet soup.

The retina and retinal pigment epithelium are involved. Lesions are usually identified during a veterinary ophthalmology exam or through screening programs, not because owners notice an obvious early sign.

  • CMR is inherited, so breeding decisions matter.
  • Different numbered forms may have different test targets and breed relevance.
  • Eye exams may reveal multifocal retinal lesions even when the dog seems visually normal.
  • Genetic testing helps identify affected, carrier, and clear dogs when the correct test exists for the breed/subtype.

This parent page is the overview. The subtype pages are where the specific testing details belong, because retinal genetics already has enough chaos without us helping.


What This Means for Life With This Dog

For owners, CMR usually means eye screening, understanding whether vision is affected, and knowing whether the condition matters mainly for breeding or also for the individual dog’s daily life.

For breeders, this is a screening and pairing issue. Producing affected puppies because nobody wanted to check the right test is not “preserving lines.” It is manufacturing problems with a logo.

If a dog is diagnosed, a veterinary ophthalmologist can explain whether the lesions are stable, progressive, or visually significant.


Can It Be Fixed?

CMR cannot be cured. Management is usually monitoring, ophthalmology follow-up when needed, and responsible genetic testing or breeding decisions. Treatment depends on whether there are secondary complications, which are not the default for every dog.


Symptoms Owners May Notice

Often no obvious signs: Many dogs are identified through screening, not because the owner noticed dramatic vision loss. The retina is sneaky like that.

Abnormal eye exam findings: A vet or ophthalmologist may see multifocal retinal lesions, folds, or changes during a dilated eye exam.

Possible vision changes: Some dogs may have vision concerns depending on severity, but not every affected dog is obviously blind or struggling.

Breeding-test concern: Carrier and affected status matter for breeding decisions even when the dog appears normal at home.


Treatment Options

Veterinary ophthalmology exam: A dilated eye exam helps document retinal lesions, monitor progression, and separate CMR from other retinal problems that can look similar to normal humans with no fancy eye tools.

Genetic testing: DNA testing should match the suspected subtype and breed. Testing the wrong thing and declaring victory is how people turn science into decoration.

Monitoring and breeding management: Most management involves follow-up exams, documenting vision status, and making responsible breeding choices based on test results and ophthalmic findings.


Recovery and Aftercare

Aftercare is usually monitoring rather than daily medication. Owners should keep ophthalmology recommendations, track any vision changes, and make sure breeding dogs are tested appropriately for the relevant subtype.


What Happens If You Wait

Waiting mostly hurts breeding decisions and clarity.

For a pet dog, delay may mean missing progression or confusing CMR with another retinal disease. For breeding dogs, delay means carriers and affected dogs can be used irresponsibly before anyone admits the eye problem exists.


Cost Reality Check

CMR costs depend on whether the dog needs ophthalmology screening, genetic testing, follow-up exams, or evaluation for vision changes.

Care Level What It May Include Estimated Cost
Initial workup General exam, ophthalmology screening, or initial eye evaluation. $150-$600
Ongoing management Genetic testing, repeat eye exams, documentation for breeding programs, and monitoring. $200-$1,000+
Severe case Specialist monitoring, advanced diagnostics, or investigation of additional eye disease if vision changes are present. $1,000-$3,000+

Subtype testing: The cost depends on which test is needed and whether it is part of a breed panel or separate test.

Ophthalmology access: Specialist exams cost more than a quick general exam, mostly because eyeballs are tiny expensive planets.

Breeding documentation: Breeders may need repeat certifications, DNA documentation, and test records.

Vision concerns: If the dog has actual vision change, additional diagnostics may be needed.


Budget Reality Check

Budget Item Estimated Cost
Ophthalmology exam $150-$500+
Genetic test or breed panel $75-$250+
Repeat monitoring exam $150-$500+
Advanced eye diagnostics $500-$1,500+
Breeding documentation and follow-up $200-$1,000+

Lifetime Cost Reality

Case Pattern Possible Lifetime Cost
Screening-only case $150-$700+
Monitoring and genetic testing case $500-$2,000+
Complicated eye-disease case $1,500-$5,000+

Related Health Watch Pages

This condition has specific variants or subpages with their own testing, breed relevance, or management details. Start here, then use the links below when the exact subtype matters.


Tell Me What I Should Really Expect

CMR is an inherited retinal condition where the subtype matters. A lot.

The parent page gives the overview, but CMR1, CMR2, and CMR3 should each be checked against current lab and breed data before final publish. Eye genetics is not the place to play “close enough.”